THE SANOFI PASTEUR INFLUENZA VACCINE PORTFOLIO 2019 …
THE SANOFI PASTEUR INFLUENZA VACCINE PORTFOLIO
SIMPLIFY YOUR INFLUENZA VACCINE CHOICES FOR PERSONS 6 MONTHS OF AGE AND OLDER
Packaging
Syringes and Vials
Ages1-3
Presentation1-3
Dosing Schedule1-4
CPT?a Codes and Coverage5
65 years
of age and older
0.5-mL
prefilled syringe
1 dose
90662
Covered by most health plans and Medicare Part B
2019-2020 SEASON
NDCb Information5
Package NDC
Unit NDC
49281-0405-65
49281-0405-88
EMRc Code
18 years
of age and older
0.5-mL
prefilled syringe
1 dose
90682
Covered by most health plans and Medicare Part B
49281-0719-10
49281-0719-88
6 months through 35 months
of age
0.25-mL
prefilled syringe (pediatric dose)
90685
Covered by most health plans and Medicare Part B
49281-0519-25
0.25-mL prefilled syringe (pediatric dose)
49281-0519-00
0.25-mL prefilled syringe (pediatric dose)
6 months
of age and older
6 months
of age and older
0.5-mL
prefilled syringe
0.5-mL
single-dose vial
5-mL
multidose vial
1 or 2 doses
Per Advisory Committee on Immunization Practices (ACIP) guidance, children 6 months through 8 years of age require 2 doses of influenza vaccine (given at least 4 weeks apart) in the flu season, if they are considered inadequately primed.
90686
Covered by most health plans and Medicare Part B
90687 (0.25-mL dose)
Covered by most health plans and Medicare Part B
90688 (0.5-mL dose)
Covered by most health plans and Medicare Part B
49281-0419-50
0.5-mL prefilled syringe
49281-0419-10
0.5-mL single-dose vial
49281-0631-15
5-mL multidose vial
49281-0419-88
0.5-mL prefilled syringe
49281-0419-58
0.5-mL single-dose vial
49281-0631-78
5-mL multidose vial
a CPT (Current Procedural Terminology) is a registered trademark of the American Medical Association. b NDC = National Drug Code. c EMR = Electronic medical record.
INDICATION FOR FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT, AND FLUZONE HIGH-DOSE VACCINES
Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines are indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus(es) contained in each vaccine. Flublok Quadrivalent vaccine is approved for use in persons 18 years of age and older. Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older. Fluzone High-Dose vaccine is approved for use in persons 65 years of age and older.
IMPORTANT SAFETY INFORMATION FOR FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT, AND FLUZONE HIGH-DOSE VACCINES
Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine (including egg protein for Fluzone Quadrivalent and Fluzone High-Dose vaccines) or after a previous dose of the respective vaccine. In addition, Fluzone Quadrivalent and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction after a previous dose of any influenza vaccine.
If Guillain-Barr? syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine should be based on careful consideration of the potential benefits and risks.
In adults, the most common local and systemic adverse reactions to Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines include pain at the injection site; headache and myalgia. In children, the most common reactions to Fluzone Quadrivalent vaccine include pain, erythema, and swelling at the injection site; myalgia, malaise, and headache (irritability, abnormal crying, drowsiness, appetite loss, vomiting, and fever in young children). Other adverse reactions to these vaccines may occur. Vaccination with Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.
Before administration, please see the full Prescribing Information for Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine.
References: 1. Fluzone High-Dose vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc. 2. Flublok Quadrivalent vaccine [Prescribing Information]. Meriden, CT: Protein Sciences Corporation. 3. Fluzone Quadrivalent vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc. 4. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices--United States, 2018?19 influenza season. MMWR. 2018;67(3):1-20. 5. Sanofi Pasteur Inc. Data on file, 2019.
SANOFI PASTEUR. Discovery Drive. Swiftwater, Pennsylvania 18370. sanofipasteur.us
SAUS.SFLU.19.03.1821
?2019SanofiPasteurInc.
3/19
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- nct number nct03308825 quadrivalent and high dose
- 2017 2018 influenza vaccine dosage chart
- 2019 20 seasonal influenza vaccine dosage for children
- fluzone quadrivalent canada
- the sanofi pasteur influenza vaccine portfolio 2019
- vaccines for children 2019 2020 seasonal influenza
- fluzone package insert
- pediatric adult influenza vaccine 2019 2020
Related searches
- influenza vaccine code 2019 medicare
- sanofi pasteur flu vaccine 2019
- sanofi pasteur flu vaccine ingredients
- sanofi pasteur flu vaccine delay
- sanofi pasteur influenza vaccine portfolio
- sanofi pasteur influenza vaccine 2019
- sanofi pasteur quadrivalent influenza vaccine
- sanofi pasteur vaccine information
- sanofi pasteur vaccine customer service
- sanofi pasteur flu vaccine return
- sanofi pasteur vaccine return form
- sanofi pasteur influenza vaccine